Posted Jan. 13, 2014 at 11:22 a.m.

Premium Lock GSK lands 'breakthrough' FDA designation for lung cancer treatment

Published: 2014-01-13 11:22:51
Updated: 2014-01-13 11:22:51

GSK's HQ in London       GSK's HQ in London
Tags: GSK

Good news, bad news for GlaxoSmithKline on Monday: A treatment for metastatic lung cancer receives "Breakthrough Therapy" designation from the FDA. However, GSK also says it has dropped development of a muscular dystrophy treatment....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll